Cas:2541-69-7 7-Methyltetraphene manufacturer & supplier

Chemical Name:7-Methyltetraphene

CAS.NO:2541-69-7

Synonyms:7-Methyltetraphene;7-METHYLBENZ(A)ANTHRACENE;3,4-Benz-9-methylanthracene;7-Methylbenzanthracene;EINECS 219-819-1;7-Methylbenz[a]anthracene;7-Mba;10-Methyl-1,2-benzanthracene;Benz[a]anthracene, 7-methyl-

Molecular Formula:C₁₉H₁₄

Molecular Weight:242.314

HS Code:2902909090

Physical and Chemical Properties:

Melting point:140ºC

Boiling point:449.4±12.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.748

PSA:

Exact Mass:242.109543

LogP:6.37

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 7-Methyltetraphene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benz[a]anthracene, 7-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,4-Benz-9-methylanthracene Use and application,7-Mba technical grade,usp/ep/jp grade.

Related News: If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. 7-Methyltetraphene manufacturer Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. 7-Methyltetraphene supplier If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. 7-Methyltetraphene vendor The firm announced its own acquisition of California-based chemical, manufacturing and control (CMC) advisor Chamow & Associates back in January to bolster Alira’s biologics manufacturing, quality assurance and regulatory compliance business. Further yet, 12 months ago, Alira picked up French consulting firm Care Factory for its data science experts and electronic health record database knowledge. 7-Methyltetraphene factory The agency said it was not yet ready to authorize Emergent BioSolutions Inc’s (EBS.N) plant for manufacturing the J&J vaccine.